MiNK Therapeutics, Inc.

US$10.35As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:INKTHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (43.31%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 0.45
PE TTM —
TSR TTM (26.28%)
Mkt cap US$52.82M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$13
22.54%
3.07%
Hold 9|2|9|4|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.13
0.14
0.14
0.14
21.17%
17.03%
20.56%
14.57%
Revenue$M
2.909
2.851
2.917
2.883
7.07%
1.43%
(0.91%)
(0.28%)
Peers (US$52.82M)
Cap (US$)
PE
52.40M
—
52.58M
—
Capital
TTM
5Y
10Y
Leveragex
1.823
0.094
0.096
EBIT/Intx
0.862
0.090
0.109
Own earn%
374.70
80.06
66.16
Sh yield%
9.15
21.86
20.66
Owners
Insiders/Inst%
8.79
84.29
Short interest%
1.22
SBC / revenue%
0.32
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
21–28
$1 testx
—
Incr. ROIC%
5